| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.88B | 10.54B | 11.90B | 11.53B | 12.56B | 9.33B |
| Gross Profit | 1.65B | 1.51B | 1.76B | 1.81B | 1.96B | 1.60B |
| EBITDA | 764.77M | 899.47M | 1.12B | 1.35B | 1.10B | 679.00M |
| Net Income | 842.50M | 790.94M | 922.02M | 997.02M | 681.05M | 433.34M |
Balance Sheet | ||||||
| Total Assets | 16.99B | 15.10B | 14.69B | 13.82B | 12.99B | 12.34B |
| Cash, Cash Equivalents and Short-Term Investments | 2.77B | 5.80B | 3.77B | 3.63B | 5.61B | 4.28B |
| Total Debt | 2.27B | 3.04B | 305.32M | 2.39B | 362.29M | 607.18M |
| Total Liabilities | 8.22B | 6.87B | 6.91B | 6.60B | 6.49B | 6.36B |
| Stockholders Equity | 8.20B | 7.66B | 7.26B | 6.69B | 5.96B | 5.40B |
Cash Flow | ||||||
| Free Cash Flow | 1.08B | 840.26M | 1.10B | 967.16M | 3.51B | 514.43M |
| Operating Cash Flow | 1.27B | 1.03B | 1.22B | 1.06B | 3.60B | 582.28M |
| Investing Cash Flow | -1.82B | -1.19B | -1.32B | -2.01B | -2.10B | 272.58M |
| Financing Cash Flow | -255.72M | -279.45M | -336.17M | -346.34M | -140.53M | -119.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$13.27B | 4.32 | 11.57% | 4.26% | 9.84% | 27.75% | |
75 Outperform | HK$14.38B | 3.69 | 10.76% | 4.49% | -4.80% | 2.58% | |
66 Neutral | HK$100.50B | 4.80 | 14.20% | 4.77% | 15.34% | 20.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$34.21B | 13.19 | 13.75% | 3.41% | 11.08% | 59.37% | |
57 Neutral | HK$71.43B | 19.02 | 7.49% | 7.28% | 14.66% | 30.39% | |
47 Neutral | HK$104.94M | -0.54 | -19.04% | ― | -43.23% | -39.10% |